The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels

Bioorganic & Medicinal Chemistry Letters
1997.0

Abstract

UK-78,282 was identified in a human T cell 86Rb efflux high-throughput screen of our compound libraries. This compound was found to be a potent and selective blocker of human T cell voltage-gated K ÷ channels and to inhibit T cell activation. The SAR around UK-78,282 and a general pharmacophore hypothesis are presented in this communication.

Knowledge Graph

Similar Paper

The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels
Bioorganic & Medicinal Chemistry Letters 1997.0
Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3:  Synthesis and Immunosuppressive Activity
Journal of Medicinal Chemistry 2004.0
Angular Methoxy-Substituted Furo- and Pyranoquinolinones as Blockers of the Voltage-Gated Potassium Channel Kv1.3
Journal of Medicinal Chemistry 2001.0
Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype
Bioorganic & Medicinal Chemistry Letters 2022.0
Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels
Bioorganic & Medicinal Chemistry Letters 2008.0
Discovery of potent T-type calcium channel blocker
Bioorganic & Medicinal Chemistry Letters 2007.0
Structure–activity relationship exploration of Kv1.3 blockers based on diphenoxylate
Bioorganic & Medicinal Chemistry Letters 2012.0
Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators
European Journal of Medicinal Chemistry 2011.0
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators
Journal of Medicinal Chemistry 2020.0